Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

Kazutomo Niwa; Daisuke Kawakita; Toshitaka Nagao; Hideaki Takahashi; Takashi Saotome; Masashi Okazaki; Keisuke Yamazaki; Isaku Okamoto; Hideaki Hirai; Natsuki Saigusa; Yuichiro Tada

doi:https://doi.org/10.1038/s41598-020-73965-6

doi.org/10.1038/s41598-020-73965-6

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

,

,

..., Yuichiro Tada

18

Scientific Reports4.60

Volume: 10, Issue: 1

Published: Oct 12, 2020

Abstract

Although immune-checkpoint inhibitors (ICIs) are effective against various cancers, little is known regarding their role in salivary gland carcinoma (SGC) treatment. Therefore, we evaluated the efficacy and safety of nivolumab monotherapy in patients with recurrent and/or metastatic SGC. In this multicentre retrospective study, nivolumab (240 mg) was administered every 2 weeks. The overall response rate (ORR), progression-free survival (PFS),...

Paper Fields

Paper Details

Title

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

DOI

doi.org/10.1038/s41598-020-73965-6

Published Date

Oct 12, 2020

Journal

Scientific Reports

Volume

10

Issue

1

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History